Drugs / Plasma with neutralizing autoantibodies to Type I Interferons
Plasma with neutralizing autoantibodies to Type I Interferons
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07067099 | Sep 2025 → Jun 2026 overdue | hidradenitis suppurativa | Centre Hospitalier Universitaire de Besancon | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasma with neutralizing autoantibodies to Type I Interferons | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07067099 ↗ |
| Action | Inhibit | “neutralizing autoantibodies to Type I Interferons” NCT07067099 ↗ |
| Modality | Protein / enzyme biologic | “plasma containing high titre anti-IFN-1 autoantibodies” NCT07067099 ↗ |
| Route | Other | “Transfusion of one unit of plasma containing high titre anti-IFN-1 autoantibodies” NCT07067099 ↗ |